Small and mid-sized biotech companies could see M&A action in the second half
designer491 As many large pharmaceutical companies continue to grapple with looming patent cliffs that will impact sales of key drugs, ...
Tag: Biotech
Puma Biotech Begins Phase II Trial for Lung Cancer Therapy By Investing.com
© Reuters. LOS ANGELES - Puma Biotechnology, Inc. (NASDAQ: NASDAQ :) has begun a Phase II clinical trial to evaluate ...
JP Morgan event in focus amid biotech M&A and obesity frenzy
Lina Moiseienko/iStock Publishing via Getty Images Recent momentum in biotech deals, growing interest in weight-loss drugs and the popularity of ...
Pharma and Biotech Deal Values Jump 35% in 2023 (NYSE:BMY)
NISIT RAWO/iStock via Getty Images Pharma and biotech deal values rose 35% in 2023, as major drugmakers face patent cliffs ...
Give biotech a chance for the planet’s sake, EU lawmakers urged
European Union lawmakers are being urged to avoid too much risk aversion from holding back the potential of the homegrown ...
Morningstar’s optimism about biotech; Pfizer is among the options
Biotech stocks have suffered this year amid concerns about government moves to cap drug prices and scrutinize acquisitions. Investors are ...
Biotech proved to be a surprisingly bright spot in the 2022 startup correction
no boot sector it was completely immune to the uncertainty of the 2022 market, except maybe the AI, but some ...
Recommended.
